About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Apr 02, 2020... REHOVOT, ISRAEL—April 2, 2020—Along with fever, cough, and shortness of breath, many COVID-19 patients report a temporary loss of sense of smell. It appears that olfactory loss is significantly greater in coronavirus patients compared to the loss often experienced during a cold and, less commonly, in influenza (non-COVID-19) patients. In some countries, such as France, a patient who claims to have sudden onset of olfactory loss will be diagnosed as a coronavirus patient – without even being tested. A similar approach is being considered in the U.K. Based on this data, Weizmann Institute of Science investigators, in collaboration with Israel’s Edith Wolfson Medical Center, developed SmellTracker – an online platform that enables self-monitoring of one’s sense of smell – in order to detect early signs of COVID-19, or in the absence of other symptoms.
Jun 01, 2020...
Prime Minister Benjamin Netanyahu told the public last week to “return to normalcy, get a cup of coffee, a glass of beer… have fun” – and that is what most Israelis did.
But that return to normalcy appears to have runneth over, and the cup is apparently no longer half full.
As Israelis declined to comply with social-distancing directives, children returned to school, restaurants opened, and the number of people screened for the novel coronavirus dropped, the country quickly started to see a surge in active cases of SARS-CoV-2.
https://www.weizmann-usa.org/news-media/in-the-news/covid-19-is-all-about-the-curve/
Apr 26, 2020... Prof. Doron Lancet of the Department of Molecular Genetics at the Weizmann Institute of Science says that the Covid-19 curve has developed in the same trajectory in many countries regardless of their lockdown policies. By his reckoning, the significant statistic is not the number of cases but the pattern of development, which is similar in every country including Israel and is currently falling. According to Lancet, it was not the lockdown that led to the change in direction in Israel, or at least not just the lockdown, but something natural in the development of the disease and he insists that a comparative analysis proves this. By this logic, even the complete relaxation of the lockdown (although this is not necessarily what he recommends) would not result in the kind of figures being seen in Italy or New York.
May 08, 2020...
It started with a tweet. Alpha Lee, co-founder and chief scientific officer of machine-learning company PostEra, read on Twitter that Diamond Light Source, the UK’s national synchrotron facility, had identified a set of chemical fragments that attach to an important coronavirus protein.
Lee wondered if his company, formed just six months earlier, could help connect the dots from fragments to viable drugs to fight COVID-19. PostEra uses AI algorithms to map routes for drug synthesis to speed the drug discovery process. But to do so, they would need some design ideas. So Lee asked the Internet.
May 27, 2020...
Gallons of Israeli blood will be packed in liquid nitrogen on Monday and rushed to America’s national health agency, in the hope it will help to solve some of the biggest mysteries of the coronavirus.
Daniel Douek, the scientist who collected the thousands of samples, conducted an initial analysis and prepared them for shipment, said that he is “extremely excited” that they are leaving for the US.
May 11, 2020... Researchers in Israel have succeeded in determining the biological processes that characterize seriously ill COVID-19 patients, as compared to those who are only mildly affected. The researchers, headed by Prof. Ido Amit from the Department of Immunology at the Weizmann Institute of Science in Rehovot, examined the differences between those who were seriously ill and lightly ill. They based their analysis partly on the virus’ activity at the single cell level.
May 09, 2020...
Collecting data and maintaining privacy do not have to rule each other out, according to computer scientist Shafi Goldwasser.
Goldwasser, 61, a professor at MIT, UC Berkeley, and Israel’s Weizmann Institute of Science, is a Turing Award and Gödel Prize laureate. She is also the co-founder and chief scientist at Duality Technologies Inc., a Tel Aviv and Maplewood, New Jersey-based startup that develops technologies for sharing and analyzing encrypted and anonymized data.
Apr 05, 2020...
Is your sense of smell suddenly not working very well? Not to panic you, but sudden olfactory loss has emerged as a significant symptom in about 60 percent of COVID-19 patients.
In fact, in France, people reporting a dramatic drop-off in their ability to smell are automatically assumed coronavirus-positive.
Based on this data, Weizmann Institute scientists, in collaboration with Wolfson Medical Center in Holon, developed SmellTracker – an online platform that enables self-monitoring of smell in order to detect early signs of COVID-19.
https://www.weizmann-usa.org/news-media/in-the-news/how-to-reopen-society-more-quickly/
Apr 21, 2020...
Countries are facing stark and terrible choices now. End the lockdown to restart their economies but risk the ravages of the Covid-19 pandemic, or prolong the lockdown and inflict more heavy damage on people’s lives and on the economy.
Large-scale testing is unfeasible in some of the most affected countries and antibody testing to detect immunity is struggling with reliability issues. That makes it difficult to identify the subpopulations that can be allowed out of the lockdown and to determine how long others need to remain sequestered.There is a way out. According to Uri Alon and Ron Milo at Israel’s Weizmann Institute of Science, we can exploit the way coronavirus develops in human beings to begin to open our societies for four days out of every 14.
May 14, 2020...
Throughout the COVID-19 outbreak, one of the greatest mysteries to confound researchers has been figuring out why the disease leaves some people almost completely unharmed, while others suffer serious conditions and die.
The answer, according to Israeli scientists, is that lungs of the worst-affected patients become riddled with immune cells that exacerbate the pathogen’s impact instead of fighting it. In patients who are less affected by the disease, this doesn’t happen, says the team from the Weizmann Institute of Science.